ipilimumab

본문 바로가기


Home > Product > ipilimumab
Selling leads
ipilimumab
Posting date : Jul 22, 2025
Membership
Free Member Scince Jun 27, 2025
FOB Price
detailed discussion
Min. Order Quantity
1
Supply Abillity
hundreds of kgs
Port
Shanghai Port
Payment Terms
detailed discussion
Package
Convenient package
Keyword :
Category
Contact
Lena
Selling Leads Detail
Company Info
 
Quick Detail
Place of Origin
China [CN]
Brand Name
Royal
Model Number
+86 15242851296
HS-CODE
-
Package & Delivery Lead Time
Package
Convenient package
Detailed Description

Ipilimumab is an anti-CTLA-4 antibody. CTLA-4 is expressed on the surface of T cells and is the first inhibitory receptor target used in clinical research. CTLA-4 exerts inhibitory functions during the T cell activation stage: After T cell activation, CTChemicalbookLA-4 is upregulated on the surface of T cells. On the one hand, it competitively binds to the costimulatory molecule B7 with CD28; on the other hand, it conducts inhibitory signals to terminate cell activation. CTLA-4 plays a crucial role in maintaining the homeostasis of the immune system.


ECROBOT CO., Ltd, Business Registration Number : 220-88-71747, CEO J.W.Park, TEL : +82-2-552-7676, E-mail : E-mail : Contact us
Address : (Hwanghwa B/D 11F, Yeoksam-dong)320, Gangnam-daero, Gangnam-gu, Seoul, South Korea
About Us Privacy Policy Terms of use Copyright © 2000-2026 ECROBOT.COM. All rights reserved.
Top